ENSC

Ensysce Biosciences Inc

0.3310

-0.0192-5.48%

Opening11:09 05/11 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.3767/0.3502

TODAY RANGE0.3010-0.3789

VOL79.90M

MARKET CAP3.07M

52 WEEK RANGE0.3010-2.750

AVG VOL (3M)5.94M

% TURNOVER861.16%

TURNOVER--

P/E (TTM)-0.0832

% RANGE22.24%

EPS(TTM)-3.9790

P/E(FORWARD)-0.0935

P/B0.4712

BVPS0.7025

DIVIDEND--

P/S0.2989

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.14M

SHARES OUTSTANDING9.28M

NEXT EARNINGS05/11-05/15

FREE FLOAT3.44M

LOT SIZE1

EX-DATE12/06/2024

News

Press Releases

Financial Reports

Profile

PUBT·3d ago
Ensysce CEO speaks at Pain Therapeutics Summit Europe in Amsterdam
PUBT·04/20 18:14
Ensysce Biosciences posts investor presentation on TAAP, MPAR opioid pain programs
TipRanks·04/16 13:08
Ensysce secures IRB approval of final phase of PF614-MPAR-102 study
PUBT·04/16 12:09
Ensysce gets IRB clearance to start final phase of PF614-MPAR-102 study
TipRanks·04/09 10:12
Ensysce Biosciences files to sell 20.34M shares of common stock for holders
TipRanks·04/08 10:34
Ensysce Biosciences Secures $2 Million Private Financing
TipRanks·04/07 12:52
Ensysce Biosciences secures second financing from 2025 agreement
Reuters·04/07 12:06
Ensysce Biosciences closes USD 2 million convertible preferred stock private placement
TipRanks·04/03 20:27
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
Reuters·04/03 20:15
Ensysce Biosciences director Curtis Rosebraugh resigns from board
Reuters·03/30 21:02
Ensysce Biosciences Q4 net loss narrows to $2.8 mln
Seeking Alpha·03/30 20:53
Ensysce Biosciences GAAP EPS of -$0.75 beats by $0.51
Reuters·03/30 20:50
ENSYSCE BIOSCIENCES Q4 NET INCOME USD -2.8 MILLION
Reuters·03/30 10:02
Ensysce Biosciences director Lee Rauch resigns from board amid retention package dispute
TipRanks·03/23 12:30
Ensysce Biosciences Corrects Series B Preferred Stock Designation

Same Industry

Name/Symbol

Change%

Price

ENSC

Regeneron Pharmaceuticals

REGN

+0.82%

714.89

GRDX

BNTX

United Therapeutics Corp.

UTHR

-0.74%

564.94

SIGA

VRTX

MRNA

CRL

MEDP

Talphera Inc

TLPH

+2.89%

0.9037

ICON PLC

ICLR

-0.41%

124.49

China Biologic

CBPO

0.00%

119.99

IQV

MOLECULAR PARTNERS AG

MOLN

0.00%

4.100

PRAH

Gilead Sciences Inc

GILD

-2.04%

131.33

Arcturus Therape

ARCT

+3.60%

9.22

INCY

APVO

Biospecifics

BSTC

0.00%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.